MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore how genetic testing aids in diagnosing Type II complement component 8 deficiency, enhancing treatment strategies and family planning for this rare immune disorder.
Explore how genetic testing reveals key insights into Vesicoureteral Reflux 3, enabling early detection, personalized treatment, and informed family planning.
Explore how genetic testing enhances the diagnosis and management of von Willebrand disease type 2, enabling precise subtyping and personalized treatment approaches.
Explore 46,XY sex reversal 5, a genetic disorder caused by SRY gene mutations. Learn how genetic testing aids in diagnosis, treatment, and family planning.
Explore acute infantile liver failure, a rare mitochondrial disorder. Learn how genetic testing aids in early diagnosis, personalized treatment, and family planning.
Uncover how genetic testing aids in diagnosing Amelogenesis Imperfecta Type 2A3, offering insights into personalized treatment and preventive dental care.
Explore the impact of genetic testing on diagnosing and managing Asphyxiating Thoracic Dystrophy 3, highlighting DYNC2H1 mutations and personalized treatment options.
Explore how genetic testing revolutionizes the diagnosis and management of Atrial Septal Defect 6, offering early diagnosis, personalized treatment, and family planning insights.